《盈警響號》智美體育(01661.HK)料上半年錄虧損
智美體育(01661.HK)公布,集團預期今年上半年錄得期間虧損。主要由於集團上半年舉辦馬拉松賽事數量下降;及於今年6月18日,中國田徑協會公布今年下半年為「奔跑中國」馬拉松舉辦的比賽的時間表。集團董事會自時間表注意到,除濟南馬拉松外,並無任何奔跑中國馬拉松賽事將由中國田徑協會與集團共同運作。
集團指,已與中國田徑協會進行多輪磋商,以確定未來奔跑中國馬拉松運作方式。根據目前的談判進度,並結合專業顧問的意見,公司預期集團未來將不再具備奔跑中國馬拉松獨家營運權。公司預計有機會需為取得奔跑中國馬拉松項目產生的商譽及無形資產進行減值撥備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.